Literature DB >> 12857532

Cognitive-behavioral treatment of social phobia: new advances.

Jonathan D Huppert1, Deborah A Roth, Edna B Foa.   

Abstract

Cognitive-behavioral treatment (CBT) for social phobia is an effective treatment for many patients, but some patients do not benefit from the treatments and many remain symptomatic. Therefore, researchers have been examining techniques that may improve treatment outcome. In this paper, recent psychopathology and treatment outcome research, much of which supports the expectation that a second-generation CBT treatment may further improve outcome, are discussed. Finally, the authors present a number of CBT techniques that are tailored for the individual treatment of patients with social phobia. These methods, based on comprehensive CBT developed by Foa et al. and on cognitive therapy for social phobia developed by Clark et al. include developing an idiographic model for the patient, conducting safety behaviors experiments, providing video feedback after cognitive preparation, developing a hierarchy, conducting in vivo exposures and other behavioral experiments, imaginal exposure, social skills training, assertiveness training, and behavioral activation for depression.

Entities:  

Mesh:

Year:  2003        PMID: 12857532     DOI: 10.1007/s11920-003-0058-5

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  30 in total

1.  Quality of life following cognitive behavioral treatment for social anxiety disorder: preliminary findings.

Authors:  W Eng; M E Coles; R G Heimberg; S A Safren
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

2.  How do I look with my minds eye: perspective taking in social phobic imagery.

Authors:  A Wells; D M Clark; S Ahmad
Journal:  Behav Res Ther       Date:  1998-06

3.  Interpretative inferences when reading about emotional events.

Authors:  C Hirsch; A Mathews
Journal:  Behav Res Ther       Date:  1997-12

4.  Cognitive biases in generalized social phobia.

Authors:  E B Foa; M E Franklin; K J Perry; J D Herbert
Journal:  J Abnorm Psychol       Date:  1996-08

5.  Cognitive factors in social anxiety and its treatment.

Authors:  M P Lucock; P M Salkovskis
Journal:  Behav Res Ther       Date:  1988

6.  Emotional processing of fear: exposure to corrective information.

Authors:  E B Foa; M J Kozak
Journal:  Psychol Bull       Date:  1986-01       Impact factor: 17.737

7.  Impaired positive inferential bias in social phobia.

Authors:  C R Hirsch; A Mathews
Journal:  J Abnorm Psychol       Date:  2000-11

8.  The observer perspective: biased imagery in social phobia, agoraphobia, and blood/injury phobia.

Authors:  A Wells; C Papageorgiou
Journal:  Behav Res Ther       Date:  1999-07

9.  Comorbid anxiety and mood disorders among persons with social anxiety disorder.

Authors:  Brigette A Erwin; Richard G Heimberg; Harlan Juster; Melissa Mindlin
Journal:  Behav Res Ther       Date:  2002-01

10.  Cognitive therapy for social phobia: individual versus group treatment.

Authors:  U Stangier; T Heidenreich; M Peitz; W Lauterbach; D M Clark
Journal:  Behav Res Ther       Date:  2003-09
View more
  3 in total

1.  Effects of Group-Based CBT on Post-Event Processing in Children with Social Anxiety Disorder Following an Experimental Social Stressor.

Authors:  Julia Asbrand; Julian Schmitz; Martina Krämer; Kai Nitschke; Nina Heinrichs; Brunna Tuschen-Caffier
Journal:  J Abnorm Child Psychol       Date:  2019-12

Review 2.  Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach.

Authors:  Michiel Kuijpers; Judith E van Zanden; Petra W Harms; Hubert E Mungroop; Massimo A Mariani; Theo J Klinkenberg; Wobbe Bouma
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

3.  Post-earthquake dizziness syndrome following the 2016 Kumamoto earthquakes, Japan.

Authors:  Toru Miwa; Hidetake Matsuyoshi; Yasuyuki Nomura; Ryosei Minoda
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.